R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 45,000 shares at $68.00 ($3.1M) on 2011-10-28, disclosed to the SEC on 2011-10-31.
Open-market sale of $3.1M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.00 | 18,880 | $1.3M | 42.0% |
| 2 | $68.00 | 26,120 | $1.8M | 58.0% |
| Total | $68.00 avg | 45,000 | $3.1M | 100% |
| Filing → |
| ALXN | SELL | 2013-05-23 | $4.1M | — | Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |